All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

ENGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $786,480.75

enGene Insider Trading History Chart

enGene Share Price & Price History

^$9.00

+0.30 (1.20%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

enGene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/22/2024	De Solidarite Des Travai Fonds	Major Shareholder	Sell	47,854	$15.00	$717,810.00	3,036,153
4/18/2024	De Solidarite Des Travai Fonds	Major Shareholder	Sell	4,575	$15.01	$68,670.75	3,084,107

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

SEC Filings (Institutional Ownership Changes) for enGene (NASDAQ:ENGN)

64.16% of enGene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

enGene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2024	Janus Henderson Group PLC	1,000,000	$17.10M	0.0%	N/A	2.295%
5/15/2024	Altitude Crest Partners Inc.	120,289	$2.04M	0.9%	N/A	0.276%
3/7/2024	Fcpm Iii Services B.V.	8,677,951	$80.10M	23.8%	N/A	37.408%
2/15/2024	Omega Fund Management LLC	1,131,175	$10.44M	8.5%	N/A	4.876%
2/15/2024	BVF Inc. IL	2,251,037	$20.78M	0.5%	N/A	9.703%
2/7/2024	Vivo Capital LLC	678,705	$6.26M	0.5%	N/A	2.925%

Data available starting January 2016

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Today's Range

Now: $9.00

$8.52

$9.75

50 Day Range

MA: $9.46

$7.70

$13.27

52 Week Range

Now: $9.00

$6.69

$43.00

Volume

101,260 shs

Average Volume

78,394 shs

Market Capitalization

$397.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of enGene?: enGene's top insider investors include:
De Solidarite Des Travai Fonds (Major Shareholder)
Learn More about top insider investors at enGene.

Nvidia insiders dumping shares

From Porter & Company | Ad